Li, M., Cordon-Cardo, C., Gerald, W. L., & Rosai, J. (1996). Desmoid fibromatosis is a clonal process. Human Pathology, 27(9), 939–943.
Article CAS PubMed Google Scholar
Garcia-Ortega, D. Y., Martín-Tellez, K. S., Cuellar-Hubbe, M., Martínez-Said, H., Álvarez-Cano, A., Brener-Chaoul, M., et al. (2020). Desmoid-type fibromatosis. Cancers, 12(7), 1851.
Article CAS PubMed PubMed Central Google Scholar
Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., & Bonvalot, S. (2014). Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †. Annals of Oncology, 25, iii102–iii112.
Hansmann, A., Adolph, C., Vogel, T., Unger, A., & Moeslein, G. (2004). High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer, 100(3), 612–620.
Article CAS PubMed Google Scholar
Janinis, J., Patriki, M., Vini, L., Aravantinos, G., & Whelan, J. S. (2003). The pharmacological treatment of aggressive fibromatosis: A systematic review. Annals of Oncology, 14(2), 181–190.
Article CAS PubMed Google Scholar
Penel, N., Le Cesne, A., Bui, B. N., Perol, D., Brain, E. G., Ray-Coquard, I., et al. (2011). Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): An FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Annals of Oncology, 22(2), 452–457.
Article CAS PubMed Google Scholar
Kasper, B., Ströbel, P., & Hohenberger, P. (2011). Desmoid tumors: Clinical features and treatment options for advanced disease. The Oncologist, 16(5), 682–693.
Article CAS PubMed PubMed Central Google Scholar
Bonvalot, S., Eldweny, H., Haddad, V., Rimareix, F., Missenard, G., Oberlin, O., et al. (2008). Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. European Journal of Surgical Oncology (EJSO), 34(4), 462–468.
Article CAS PubMed Google Scholar
Eastley, N., Aujla, R., Silk, R., Richards, C. J., McCulloch, T. A., Esler, C. P., et al. (2014). Extra-abdominal desmoid fibromatosis—A sarcoma unit review of practice, long term recurrence rates and survival. European Journal of Surgical Oncology (EJSO), 40(9), 1125–1130.
Article CAS PubMed Google Scholar
Stoeckle, E., Coindre, J. M., Longy, M., Binh, M. B. N., Kantor, G., Kind, M., et al. (2009). A critical analysis of treatment strategies in desmoid tumours: A review of a series of 106 cases. European Journal of Surgical Oncology (EJSO), 35(2), 129–134.
Article CAS PubMed Google Scholar
Ghert, M., Yao, X., Corbett, T., Gupta, A. A., Kandel, R. A., Verma, S., et al. (2014). Treatment and follow-up strategies in desmoid tumours: A practice guideline. Current Oncology Toronto Ont, 21(4), e642-649.
Article CAS PubMed PubMed Central Google Scholar
Ballo, M. T., Zagars, G. K., Pollack, A., Pisters, P. W., & Pollack, R. A. (1999). Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. Journal of Clinical Oncology, 17(1), 158–167.
Article CAS PubMed Google Scholar
Salas, S., Dufresne, A., Bui, B., Blay, J. Y., Terrier, P., Ranchere-Vince, D., et al. (2011). Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: A wait-and-see policy according to tumor presentation. Journal of Clinical Oncology, 29(26), 3553–3558.
Zeng, W. G., Zhou, Z. X., Liang, J. W., Hou, H. R., Wang, Z., Zhou, H. T., et al. (2014). Prognostic factors for desmoid tumor: A surgical series of 233 patients at a single institution. Tumour Biology Journal of International Society of Oncodevelopmental Biology Medicine, 35(8), 7513–7521.
Shido, Y., Nishida, Y., Nakashima, H., Katagiri, H., Sugiura, H., Yamada, Y., et al. (2009). Surgical treatment for local control of extremity and trunk desmoid tumors. Archives of Orthopaedic and Trauma Surgery, 129(7), 929–933.
Peng, P. D., Hyder, O., Mavros, M. N., Turley, R., Groeschl, R., Firoozmand, A., et al. (2012). Management and recurrence patterns of desmoids tumors: A multi-institutional analysis of 211 patients. Annals of Surgical Oncology, 19(13), 4036–4042.
Article PubMed PubMed Central Google Scholar
Goy, B. W., Lee, S. P., Eilber, F., Dorey, F., Eckardt, J., Fu, Y. S., et al. (1997). The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. International Journal of Radiation Oncology Biology Physics, 39(3), 659–665.
Article CAS PubMed Google Scholar
Micke O, Seegenschmiedt MH, German Cooperative Group on Radiotherapy for Benign Diseases. (2005). Radiation therapy for aggressive fibromatosis (desmoid tumors): Results of a national Patterns of Care Study. International Journal of Radiation Oncology Biology Physics, 61(3), 882–891.
Nuyttens, J. J., Rust, P. F., Thomas, C. R., & Turrisi, A. T. (2000). Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer, 88(7), 1517–1523.
Article CAS PubMed Google Scholar
Kindly check and update ref. [20].
Rydholm, A. (1997). Surgical margins for soft tissue sarcoma. Acta Orthopaedica Scandinavica, 68(sup273), 81–85.
Fiore, M., Rimareix, F., Mariani, L., Domont, J., Collini, P., Le Péchoux, C., et al. (2009). Desmoid-type fibromatosis: A front-line conservative approach to select patients for surgical treatment. Annals of Surgical Oncology, 16(9), 2587–2593.
Crago, A. M., Denton, B., Salas, S., Dufresne, A., Mezhir, J. J., Hameed, M., et al. (2013). A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Annals of Surgery, 258(2), 347–353. 2013 (4th) edition. Pathology (Phila). 2014 Feb;46(2):95–104.
Article PubMed PubMed Central Google Scholar
Merchant, N. B., Lewis, J. J., Woodruff, J. M., Leung, D. H., & Brennan, M. F. (1999). Extremity and trunk desmoid tumors: A multifactorial analysis of outcome. Cancer, 86(10), 2045–2052.
Article CAS PubMed Google Scholar
van Broekhoven, D. L. M., Verhoef, C., Elias, S. G., Witkamp, A. J., van Gorp, J. M. H. H., van Geel, Ba. N., et al. (2013). Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis. British Journal of Surgery, 100(9), 1214–1219.
Kasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F., et al. (2017). An update on the management of sporadic desmoid-type fibromatosis: A European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology Official Journal of European Society For Medical Oncology, 28(10), 2399–2408.
Bonvalot, S., Ternès, N., Fiore, M., Bitsakou, G., Colombo, C., Honoré, C., et al. (2013). Spontaneous regression of primary abdominal wall desmoid tumors: More common than previously thought. Annals of Surgical Oncology, 20, 4096–4102.
Ruspi, L., Cananzi, F. C., Sicoli, F., Samà, L., Renne, S. L., Marrari, A., Gennaro, N., Colombo, P., Cozzaglio, L., Politi, L. S., & Bertuzzi, A. (2021). Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach. European Journal of Surgical Oncology., 47(5), 1196–1200.
Shimizu, K., Hamada, S., Sakai, T., Koike, H., Yoshida, M., & Nishida, Y. (2020). Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: A systematic review. Japanese Journal of Clinical Oncology, 50(4), 419–424.
Kasper, B., Gruenwald, V., Reichardt, P., Bauer, S., Rauch, G., Limprecht, R., et al. (2017). Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). European Journal of Cancer, 76, 60–67.
Article CAS PubMed Google Scholar
Salas, S., Chibon, F., Noguchi, T., Terrier, P., Ranchere-Vince, D., Lagarde, P., et al. (2010). Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes, Chromosomes and Cancer, 49(6), 560–568.
Comments (0)